Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)
Claudia Stefanutti(Sapienza University of Rome), Gerald Francis Watts(The University of Western Australia), Andrea Pasta(Ospedale Policlinico San Martino), Daniele Berretti(Azienda Sanitaria Locale Roma 3), Maria Grazia Zenti(Casa di Cura Villa Garda), Annalisa Ronca(University of Parma), Federica Vacondio(University of Parma), Anna Garuti(Ospedale Policlinico San Martino), Claudia Morozzi(Policlinico Umberto I), Elda Favari(University of Parma), Dario Mesce, Santica M. Marcovina(Medpace (United States)), S. Di Giacomo, Eduardo Anglés‐Cano(Inserm), Marco Vitale(Vita-Salute San Raffaele University), Matteo Manfredini(University of Parma), Livia Pisciotta(Ospedale Policlinico San Martino)
Cited by 21
Related Papers
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
|The Lancet|2012|739
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging
|Oncotarget|2018|522
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
|The Journal of Clinical Endocrinology & Metabolism|2016|518
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
|Nature Neuroscience|2010|348